Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma

QR Code

Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Koji Nakajima, Ayumi Korekawa, Daiki Rokunohe, Hajime Nakano, Daisuke Sawamura
Format:	article
Langue:	EN
Publié:	Wiley 2021
Sujets:	anemia jaundice melanoma metastasis nivolumab Dermatology RL1-803 Immunologic diseases. Allergy RC581-607
Accès en ligne:	https://doaj.org/article/07689a31d97d491c824f04b261b45b9e
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Nivolumab-Induced Exocrine Pancreatic Insufficiency
par: Boudewijn Sweep, et autres
Publié: (2021)

A New Murine Model of Primary Autoimmune Hemolytic Anemia (AIHA)
par: Flavia Dei Zotti, et autres
Publié: (2021)

A Case of Vogt-Koyanagi-Harada Disease-Like Uveitis Induced by Nivolumab and Ipilimumab Combination Therapy
par: Keisuke Minami, et autres
Publié: (2021)

Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study
par: Morten Fink, et autres
Publié: (2021)

Autoimmune hemolytic anemia in children: Clinical presentation and treatment outcome
par: Satyam Arora, et autres
Publié: (2021)

Concomitant autoimmune hemolytic anemia and pulmonary embolism associated with mild COVID‐19: A case report
par: Abdulrahman F. Al‐Mashdali, et autres
Publié: (2021)

Effect of antibiotic use on the efficacy of nivolumab in the treatment of advanced/metastatic non-small cell lung cancer: A meta-analysis
par: Huo Geng-wei, et autres
Publié: (2021)

Nivolumab-induced new-onset seronegative rheumatoid arthritis in a patient with advanced metastatic melanoma: A case report and literature review
par: Ammar Haikal, et autres
Publié: (2018)

Ipilimumab and Nivolumab induced ventricular tachycardia in a patient with metastatic renal cell carcinoma
par: Pramod Savarapu, et autres
Publié: (2021)

Utility of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune Inflammation Index as Prognostic, Predictive Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab and Ipilimumab
par: Koji Iinuma, et autres
Publié: (2021)

Blood group discrepancy in mixed-type autoimmune hemolytic anemia in a pediatric patient
par: Minal Wasnik, et autres
Publié: (2021)

Reporte de dos casos clínicos de melanoma con metástasis cardíacas: ("Dos caras de una misma moneda")
par: Cabrera,Ignacio, et autres
Publié: (2016)

Late diagnosis of nodular melanoma of the foot in a 74-year-old Brazilian man
par: Santos,Vitorino M, et autres
Publié: (2011)

Bortezomib in autoimmune hemolytic anemia and beyond
par: Raffaella Pasquale, et autres
Publié: (2021)

MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
par: Katsuhiro Yoshimura, MD, PhD, et autres
Publié: (2021)

Melanoma metastásico con tumor primario oculto
par: Bórquez M,Pablo, et autres
Publié: (2012)

Canine autoimmune hemolytic anemia: management challenges
par: Swann JW, et autres
Publié: (2016)

Hemolytic anemia caused by hereditary pyruvate kinase deficiency in a West Highland White Terrier dog
par: Hlavac,NRC, et autres
Publié: (2012)

Cefazolin-induced hemolytic anemia: a case report and systematic review of literature
par: Elizabeth Mause, et autres
Publié: (2021)

Use of nivolumab for colon cancer with Lynch syndrome
par: G. A. Khakimov, et autres
Publié: (2020)

Adrenalectomía bilateral laparoscópica por metástasis asincrónica de melanoma: comunicación de un caso con sobrevida prolongada
par: Molina E,Roberto, et autres
Publié: (2013)

Anemia aplástica idiopática
par: GALASSO VICARI,WALTER, et autres
Publié: (1955)

RAC1 Activation as a Potential Therapeutic Option in Metastatic Cutaneous Melanoma
par: Paula Colón-Bolea, et autres
Publié: (2021)

Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma
par: Hiroto Yoneda, et autres
Publié: (2021)

First report of expansion of CD4+/CD28 null T-helper lymphocytes in adult patients with idiopathic autoimmune hemolytic anemia
par: Soha R. Youssef, et autres
Publié: (2021)

IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses
par: Taylor A. Harper, et autres
Publié: (2021)

Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma
par: Mizue Terai, et autres
Publié: (2021)

New targeted treatments for non-small-cell lung cancer – role of nivolumab
par: Zago G, et autres
Publié: (2016)

Anemia aplástica
par: URRUTIA,FIDEL
Publié: (1948)

Anemia aplástica
par: URRUTIA,FIDEL
Publié: (1948)

Risk Stratification and Treatment Algorithm of Metastatic Renal Cell Carcinoma
par: Marc-Oliver Grimm, et autres
Publié: (2021)

Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency
par: Y ZahedPasha, et autres
Publié: (2006)

Immune-Mediated Hemolytic Anemia Associated with Candidatus Mycoplasma Haematoparvum in a Splenectomized Dog in Italy
par: Rosanna Zobba, et autres
Publié: (2020)

Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review
par: Francesco Autore, et autres
Publié: (2021)

Anemias en el lactante
par: ARIZTIA,ANIBAL, et autres
Publié: (1942)

Anemia megaloblástica de la infancia
par: CASSORLA,EDUARDO, et autres
Publié: (1960)

Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature
par: Bruno Fattizzo, et autres
Publié: (2021)

LITHOLYTIC THERAPY AT THE TREATMENT OF CHOLELITHIASIS (REVIEW OF LITERATURE)
par: E. V. Razmakhnin, et autres
Publié: (2014)

Evolución prolongada en síndrome de Crigler-Najjar tipo I
par: Besa,Santiago, et autres
Publié: (2014)